Treatment For Lung Cancer
Plant Compound Berberine May Help Fight Lung Cancer
Lung cancer is the leading cause of cancer related deaths among men and women and the scientific community continues to make efforts to find new ways for lung [...]
Researchers Tested Lung Cancer Immunotherapy in Dogs
Scientists have studied a new approach that activates body’s defense mechanisms, its T cells and natural killer cells to destroy lung cancer. The study was [...]
What is Lung Biopsy?
Lung biopsy is a form of medical treatment and there can be a number of reasons for doctors recommending it. Then, there are several types of biopsy and one [...]
Personalized Blood Test to Help Selection of Lung Cancer Treatment
University of Cambridge has led a study that showed that a personalized blood test performed after lung cancer treatment could help in detection of patients [...]
FDA Approves FoundationOne CDx in Non-Small Cell Lung Cancer
U.S. Food and Drug Administration (FDA) has approved the FoundationOne CDx as a companion diagnostic to guide treatment selection for patients with non-small [...]
FDA Approves Nivolumab Plus Chemo as Neoadjuvant Therapy for NSCLC Treatment
The FDA has approved nivolumab plus platinum-doublet chemotherapy for patients with non-small cell lung cancer in the neoadjuvant setting. Nivolumab is the [...]
Adenocarcinoma Lung Cancer: Symptoms and Treatment
There are two predominant types of lung cancer: small cell lung cancer and non-small cell lung cancer. NSCLC accounts for about 80% to 85% of all lung cancers. [...]
European Commission Approves Pfizer’s Lorviqua for Advanced Lung Cancer Treatment
European Commission (EC) has granted marketing authorization for Lorviqua as monotherapy for treatment of patients with anaplastic lymphoma kinase (ALK) – [...]
Healthy Habits to Follow During and After Lung Cancer Treatment
When lung cancer is diagnosed, a person goes through various mental and financial challenges. One needs to maintain a healthy lifestyle to stay well during and [...]
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Early NSCLC
The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell [...]
Lung Cancer Treatment May Impact Daily Function in Elderly Patients
According to the new research published in Journal of the American Geriatrics Society, older adults with lung cancer may experience decline in life-space [...]